Literature DB >> 8560972

White matter microglia produce membrane-type matrix metalloprotease, an activator of gelatinase A, in human brain tissues.

T Yamada1, Y Yoshiyama, H Sato, M Seiki, A Shinagawa, M Takahashi.   

Abstract

Membrane-type matrix metalloprotease (MT-MMP) is an activator of gelatinase A (MMP-2), which has previously been found in carcinoma cells. We examined non-neurological and Alzheimer's disease brain tissues for MT-MMP by immunohistochemistry and in situ hybridization. The anti-MT-MMP antibodies gave positive staining of brain microglial cells in all the brain tissues. Positively stained microglia were found only in the white matter. The cells producing MT-MMP protein were also shown to be white matter microglia. These results provide further evidence that activated gelatinase A, which may be a processing enzyme for degradation of beta-amyloid protein, may be produced in white matter microglia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8560972     DOI: 10.1007/bf00294800

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  16 in total

1.  Proteolytic processing of beta-amyloid precursor by calpain I.

Authors:  R Siman; J P Card; L G Davis
Journal:  J Neurosci       Date:  1990-07       Impact factor: 6.167

2.  Diagnosis of Alzheimer's disease.

Authors:  Z S Khachaturian
Journal:  Arch Neurol       Date:  1985-11

3.  Secretory form of beta-amyloid precursor protein is much abundantly contained in the cerebral white matter in human brain.

Authors:  T Tokuda; K Tanaka; F Kametani; S Ikeda; N Yanagisawa
Journal:  Neurosci Lett       Date:  1994-07-04       Impact factor: 3.046

4.  Cleavage at the amino and carboxyl termini of Alzheimer's amyloid-beta by cathepsin D.

Authors:  U S Ladror; S W Snyder; G T Wang; T F Holzman; G A Krafft
Journal:  J Biol Chem       Date:  1994-07-15       Impact factor: 5.157

5.  Antigenic expression of cathepsin B in aged human brain.

Authors:  H G Bernstein; H Kirschke; B Wiederanders; D Schmidt; A Rinne
Journal:  Brain Res Bull       Date:  1990-04       Impact factor: 4.077

6.  Lysosomal proteinase antigens are prominently localized within senile plaques of Alzheimer's disease: evidence for a neuronal origin.

Authors:  A M Cataldo; C Y Thayer; E D Bird; T R Wheelock; R A Nixon
Journal:  Brain Res       Date:  1990-04-16       Impact factor: 3.252

7.  The processing of Alzheimer A4/beta-amyloid protein precursor: identification of a human brain metallopeptidase which cleaves -Lys-Leu- in a model peptide.

Authors:  J R McDermott; A M Gibson
Journal:  Biochem Biophys Res Commun       Date:  1991-09-30       Impact factor: 3.575

8.  Secretion of beta-amyloid precursor protein involves multiple cleavage sites.

Authors:  Z Zhong; J Higaki; K Murakami; Y Wang; R Catalano; D Quon; B Cordell
Journal:  J Biol Chem       Date:  1994-01-07       Impact factor: 5.157

9.  A matrix metalloproteinase expressed on the surface of invasive tumour cells.

Authors:  H Sato; T Takino; Y Okada; J Cao; A Shinagawa; E Yamamoto; M Seiki
Journal:  Nature       Date:  1994-07-07       Impact factor: 49.962

10.  Selective localization of gelatinase A, an enzyme degrading beta-amyloid protein, in white matter microglia and in Schwann cells.

Authors:  T Yamada; K Miyazaki; N Koshikawa; M Takahashi; H Akatsu; T Yamamoto
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

View more
  19 in total

Review 1.  Extracellular matrix degradation by metalloproteinases and central nervous system diseases.

Authors:  A Lukes; S Mun-Bryce; M Lukes; G A Rosenberg
Journal:  Mol Neurobiol       Date:  1999-06       Impact factor: 5.590

2.  CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice.

Authors:  Tao Sun; Scott M Gianino; Erin Jackson; David Piwnica-Worms; David H Gutmann; Joshua B Rubin
Journal:  J Neuroimmunol       Date:  2010-07-27       Impact factor: 3.478

3.  Heart failure alters matrix metalloproteinase gene expression and activity in rat skeletal muscle.

Authors:  Robson Francisco Carvalho; Rafael Dariolli; Luis Antonio Justulin Junior; Mário Mateus Sugizaki; Marina Politi Okoshi; Antonio Carlos Cicogna; Sérgio Luis Felisbino; Maeli Dal Pai-Silva
Journal:  Int J Exp Pathol       Date:  2006-12       Impact factor: 1.925

4.  Medulloblastoma displays distinct regional matrix metalloprotease expression.

Authors:  G H Vince; C Herbold; R Klein; J Kühl; T Pietsch; S Franz; K Roosen; J C Tonn
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

5.  Effects of phorbol myristate acetate (PMA) on functions of macrophages and microglia in vitro.

Authors:  M E Smith; K van der Maesen; F P Somera; R A Sobel
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

6.  Up-regulation of MMP-8 and MMP-9 activity in the BALB/c mouse spinal cord correlates with the severity of experimental autoimmune encephalomyelitis.

Authors:  P T Nygårdas; A E Hinkkanen
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

Review 7.  Proteases and the biology of glioma invasion.

Authors:  Devin K Binder; Mitchel S Berger
Journal:  J Neurooncol       Date:  2002-01       Impact factor: 4.130

8.  Regulation of matrix metalloproteinases and their inhibitor genes in lipopolysaccharide-induced endotoxemia in mice.

Authors:  A Pagenstecher; A K Stalder; C L Kincaid; B Volk; I L Campbell
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

9.  Degradation of soluble and fibrillar amyloid beta-protein by matrix metalloproteinase (MT1-MMP) in vitro.

Authors:  Mei-Chen Liao; William E Van Nostrand
Journal:  Biochemistry       Date:  2010-02-16       Impact factor: 3.162

10.  Gliomas induce and exploit microglial MT1-MMP expression for tumor expansion.

Authors:  D S Markovic; K Vinnakota; S Chirasani; M Synowitz; H Raguet; K Stock; M Sliwa; S Lehmann; R Kälin; N van Rooijen; K Holmbeck; F L Heppner; J Kiwit; V Matyash; S Lehnardt; B Kaminska; R Glass; H Kettenmann
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.